Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:47 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | Point72 Asset Management, L.P. | 1,684,032 2.500% | -1,072,090 (-38.90%) | Filing History |
| 2024-11-14 7:46 pm Sale | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | Point72 Asset Management, L.P. | 1,520,007 3.600% | -1,049,819 (-40.85%) | Filing History |
| 2024-10-23 6:01 pm Purchase | 2024-10-16 | 13G | Bright Minds Biosciences Inc. DRUG | Point72 Asset Management, L.P. | 435,000 9.700% | 435,000 (New Position) | Filing History |
| 2024-10-21 5:05 pm Purchase | 2024-10-18 | 13G | Shoals Technologies Group, Inc. SHLS | Point72 Asset Management, L.P. | 9,029,023 5.400% | 9,029,023 (New Position) | Filing History |
| 2024-10-15 5:01 pm Purchase | 2024-10-14 | 13G | aTyr Pharma, Inc. ATYR | Point72 Asset Management, L.P. | 5,039,846 6.200% | 5,039,846 (New Position) | Filing History |
| 2024-10-10 4:10 pm Purchase | 2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT | Point72 Asset Management, L.P. | 625,000 8.400% | 625,000 (New Position) | Filing History |
| 2024-09-05 4:36 pm Purchase | 2024-09-04 | 13G | Teladoc Health, Inc. TDOC | Point72 Asset Management, L.P. | 8,754,723 5.100% | 8,754,723 (New Position) | Filing History |
| 2024-07-02 6:10 pm Purchase | 2024-07-01 | 13G | Lumentum Holdings Inc. LITE | Point72 Asset Management, L.P. | 3,382,398 5.000% | 3,382,398 (New Position) | Filing History |
| 2024-06-24 4:51 pm Purchase | 2024-06-14 | 13G | UroGen Pharma Ltd. URGN | Point72 Asset Management, L.P. | 2,569,826 6.200% | 2,569,826 (New Position) | Filing History |
| 2024-06-24 4:16 pm Purchase | 2024-06-21 | 13G | Sphere Entertainment Co. SPHR | Point72 Asset Management, L.P. | 1,560,170 5.500% | 1,560,170 (New Position) | Filing History |
| 2024-06-14 4:34 pm Purchase | 2024-06-04 | 13G | Olema Pharmaceuticals, Inc. OLMA | Point72 Asset Management, L.P. | 3,225,250 5.700% | 3,225,250 (New Position) | Filing History |
| 2024-06-10 4:29 pm Purchase | 2024-06-07 | 13G | Maravai LifeSciences Holdings, Inc. MRVI | Point72 Asset Management, L.P. | 6,647,015 5.000% | 6,647,015 (New Position) | Filing History |
| 2024-05-21 4:56 pm Purchase | 2024-05-20 | 13G | Rapid7, Inc. RPD | Point72 Asset Management, L.P. | 3,121,415 5.000% | 1,243,804 (+66.24%) | Filing History |
| 2024-05-09 5:29 pm Purchase | 2024-05-02 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Point72 Asset Management, L.P. | 17,050,384 9.900% | 17,050,384 (New Position) | Filing History |
| 2024-04-26 4:15 pm Purchase | 2024-04-25 | 13G | Avid Bioservices, Inc. CDMO | Point72 Asset Management, L.P. | 3,226,006 5.100% | 3,226,006 (New Position) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-04 | 13G | Sutro Biopharma, Inc. STRO | Point72 Asset Management, L.P. | 593,291 7.900% | 593,291 (New Position) | Filing History |
| 2024-03-26 4:21 pm Purchase | 2024-03-25 | 13G | Fox Corporation FOXA | Point72 Asset Management, L.P. | 12,046,118 5.000% | 12,046,118 (New Position) | Filing History |
| 2024-03-25 4:33 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | Point72 Asset Management, L.P. | 1,882,693 7.400% | 1,882,693 (New Position) | Filing History |
| 2024-03-07 4:15 pm Purchase | 2024-03-06 | 13G | Terns Pharmaceuticals, Inc. TERN | Point72 Asset Management, L.P. | 3,921,226 6.300% | 3,921,226 (New Position) | Filing History |
| 2024-02-29 4:31 pm Purchase | 2024-02-28 | 13G | Pulmonx Corporation LUNG | Point72 Asset Management, L.P. | 1,936,083 5.000% | 389,994 (+25.22%) | Filing History |